US 12,108,761 B2
Mesostigmata mite control agent
Satoshi Nakamura, Yokohama (JP); Takehiko Inoue, Tokyo (JP); and Haruka Takeuchi, Yokohama (JP)
Assigned to MEIJI SEIKA PHARMA CO., LTD., Tokyo (JP)
Filed by MEIJI SEIKA PHARMA CO., LTD., Tokyo (JP)
Filed on Jun. 21, 2022, as Appl. No. 17/845,012.
Application 17/845,012 is a division of application No. 16/494,571, abandoned, previously published as PCT/JP2018/010445, filed on Mar. 16, 2018.
Claims priority of application No. 2017-052200 (JP), filed on Mar. 17, 2017.
Prior Publication US 2022/0312766 A1, Oct. 6, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A01N 43/42 (2006.01); A01P 7/04 (2006.01)
CPC A01N 43/42 (2013.01) [A01P 7/04 (2021.08)] 5 Claims
 
1. A Mesostigmata mite control method, said method comprising
applying an effective amount of at least one active ingredient selected from the group consisting of compounds represented by the following Formula (1), and acid addition salts of these compounds, to at least one selected from the group consisting of a Mesostigmata mite, a homoiotherm, an insect, a habitat of a Mesostigmata mite, a habitat of a homoiotherm, and a habitat of an insect:

OG Complex Work Unit Chemistry
wherein in Formula (1), R1 is —COCH3; and R2 is F or —CH3; and R3 is a t-Bu group.